Generali Investments Management’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.48M Sell
5,731
-4,351
-43% -$1.32M 0.54% 43
2026
Q1
$2.15M Sell
10,082
-26,192
-72% -$5.86M 0.5% 42
2025
Q4
$6.21M Buy
36,274
+13,878
+62% +$2.16M 1.24% 17
2025
Q3
$3M Buy
+22,396
New +$2.37M 0.63% 37

Other funds holding LRCX

Generali Investments Management's LRCX Position: Q2 2026 in Review

Generali Investments Management reduced its Lam Research (LRCX) stake by 43% in Q2 2026, selling an estimated $1.32M and leaving 5,731 shares worth $2.48M. The position accounts for 0.54% of the portfolio, ranked #43.

Generali Investments Management first reported a position in LRCX in Q3 2025 and has held it in 4 quarters since. The position peaked at $6.21M in Q4 2025. 3,123 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Generali Investments Management held 5,731 shares of Lam Research worth $2.48M as of Q2 2026.
  • Generali Investments Management sold 4,351 Lam Research shares in Q2 2026, an estimated $1.32M.
  • Lam Research made up 0.54% of Generali Investments Management's portfolio in Q2 2026, its #43 holding.
  • Generali Investments Management first reported a position in Lam Research in Q3 2025 and has held it in 4 quarters since.
  • Generali Investments Management's Lam Research position peaked at $6.21M in Q4 2025.
  • 3,123 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Generali Investments Management's 13F filing for Q2 2026, filed 10 Jul 2026.